Finance

Lists
Why is PMN down 2.64%?
Dive Deeper
PMN:NASDAQ
Promis Neurosciences Inc
$4.05
-2.64%
(-0.11) 1D
$4.00
-1.18% (-0.048)
After hours
Closed: Nov 9, 4:00:00 PM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for PMN...
Open
$4.24
High
$4.30
Low
$4.00
Mkt. cap
36.32M
Avg. vol.
270.55K
Volume
0.00
52-wk high
$27.20
52-wk low
$2.78
EPS
-$12.61
Beta
-0.15
Shares outstanding
8.97M
No. of employees
11
Open
$4.24
High
$4.30
Low
$4.00
Mkt. cap
36.32M
Avg. vol.
270.55K
Volume
0.00
52-wk high
$27.20
52-wk low
$2.78
EPS
-$12.61
Beta
-0.15
Shares outstanding
8.97M
No. of employees
11
News stories
From web sources and news partners
About Promis Neurosciences Inc
CEO-
Employees11
Founded2005
HeadquartersMississauga, Ontario, Canada
SectorHealth Care
IndustryBiotechnology
Websitepromisneurosciences.com
Analyst ratings
Based on 5 analysts giving stock ratings to PMN in the past 3 months
Strong buy
Buy
5
Hold
0
Sell
0
12-month forecast
Based on 5 Wall Street analysts offering 12 month price targets for PMN in the last 3 months.
Highest
Current $4.05
$100.00 (+2,369.14%)
Average
$40.20 (+892.59%)
Lowest
$15.00 (+270.37%)
Analyst
Recommendation
Action
Price target
Projected
Date
Ram Selvaraju
H.C. Wainwright
Buy
Reiterated
$18.00
+344.4%
11/09/2026
Boobalan Pachaiyappan
Roth MKM
Buy
Reiterated
$15.00
+270.4%
11/02/2026
Jason McCarthy
Maxim Group
Buy
Maintained
$35.00
+764.2%
08/14/2026
Eddie Hickman
Guggenheim
Buy
Reiterated
$100.00
+2,369.1%
08/14/2026
Keay Nakae
Chardan Capital
Buy
Maintained
$33.00
+714.8%
08/13/2026
Unknown Analyst
Guggenheim
Buy
Maintained
$35.00
+764.2%
07/14/2026
Pete Stavropoulos
Cantor Fitzgerald
Buy
Initiated
$39.75
+881.5%
06/29/2026
Unknown Analyst
Brookline Capital Markets
Buy
Initiated
$40.00
+887.7%
05/20/2026
Previous reportsAll values in CAD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-
-
-
-
Cost of goods sold
9.80M
9.37M
-
9.52M
Cost of revenue
9.80M
9.37M
-
9.52M
Research and development expenses
-
-
6.97M
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.95M
1.40M
1.67M
2.74M
Operating expense
1.95M
1.40M
8.64M
2.74M
Total operating expenses
11.75M
10.77M
8.64M
12.27M
Operating income
-11.75M
-10.77M
-8.64M
-12.27M
Other non operating income
170.31K
98.03K
400.52K
536.74K
EBT including unusual items
-11.58M
-10.67M
-8.24M
-11.73M
EBT excluding unusual items
-11.58M
-10.67M
-8.24M
-11.73M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-11.58M
-10.67M
-8.24M
-11.73M
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-
-
-
-
Net interest expenses
-
-
-
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps